[{"Assets_0_Q1_USD":131111000.0,"CommonStockSharesOutstanding_0_Q1_shares":20249295.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-8097000.0,"NetIncomeLoss_1_Q1_USD":-11435000.0,"StockholdersEquity_0_Q1_USD":110115000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170512"}]